Lenguajes PT ES
Tratamiento eficaz de la anemia renal y variabilidad de la hemoglobina
  • Gilbertson D, Ebben J, Collins A.
    The effect of haemoglobin variability on hospitalization and mortality.
    Nephrol Dial Transplant 2006 Jul; 21 (Suppl 4): iv169.
    Más información
  • Fishbane S, Berns JS.
    Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
    Kidney Int 2005 Sep;68(3):1337-43.
    Más información

  • Collins AJ, Brenner RM, Ofman JJ, Chi EM, Stuccio-White N, Krishnan M,
    Solid C, Ofsthun NJ, Lazarus JM.

    Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.
    Am J Kidney Dis 2005 Sep;46(3):481-8.
    Más información

  • Ebben J, Gilbertson DT, Collins AJ.
    Short-term variability of hemoglobin levels in ESRD patients.
    J Am Soc Nephrol 2005; 16: 486A.
    Más información

  • Stirling CM, Patel JK, Simpson K.
    Haemoglobin target for haemodialysis patients – is it achievable?
    Nephrol Dial Transplant. 2005 Jun;20(Suppl 5):v268 (abstract MP202).
    Más información

  • Jacobs C, Frei D, Perkins AC.
    Results of the European Survey on Anaemia Management 2003 (ESAM 2003):
    current status of anaemia management in dialysis patients, factors affecting epoetin dosage and
    changes in anaemia management over the last 5 years. Nephrol Dial Transplant. 2005
    May;20(Suppl 3):iii3-iii24.
    Más información

  • Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y,
    Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK.
    Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice
    Patterns Study (DOPPS). Am J Kidney Dis. 2004 Jul;44(1):94-111.
    Más información

  • Port FK, Pisoni RL, Bragg-Gresham JL, Satayathum SS, Young
    EW, Wolfe RA, Held PJ.
    DOPPS estimates of patient life years attributable to modifiable hemodialysis practices
    in the United States. Blood Purif. 2004 Jan;22(1):175-80.
    Más información

  • Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, DeOreo PB.
    Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int. 2003 Oct;64(4):1514-21.
    Más información

  • Ofsthun N, LaBrecque J, Lacson E, Keen M, Lazarus JM.
    The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients.
    Kidney Int. 2003 May;63(5):1908-14.
    Más información

  • Lacson E Jr, Ofsthun N, Lazarus JM.
    Effect of variability in anemia management on hemoglobin outcomes in ESRD.
    Am J Kidney Dis. 2003 Jan;41(1):111-24.
    Más información
Buscar
Búsqueda Avanzada
Política de Privacidad | Declaración Legal
Derechos Reservados © 2008 F. Hoffmann-La Roche Ltd.